International prevalence investigation targeting assessment and management of Peripheral Intravenous Cannula across 50 countries. Tweets by @pcarriv #FOAMva
Collaboration is key when talking IV! The #HMS team had an amazing visit with the @AVATAR_grp from Australia, focusing on our #PICC initiative. HMS is lucky to collaborate with such an inspiring group! #creatingchange
Liz Simcock on patient involvement #ppi in a bundle of care for patients with vascular access 👍 #wocova18 now @OMGstudy1 lead Dr. Alexandrou on pre-insertion and insertion bundles
Idle PIVs can lead to healthcare associated infections called (wait for it)... PLABSI
Internationallly, idle PIVs are being targeted in efforts to reduce hospital onset Staph aureus bacteremia
Great initial data on global PIV use in new @JHospMedicine work https://t.co/i0B6SsWPwC
A massive survey of >40,000 PIVCs in 51 countries. The current state of clinical management of IV lines seems sadly pretty poor. Huge potential for improved practice! Great work by @Claire_AVATAR and team @AVATAR_grp https://t.co/LOpUJXVAgX
Breaking #FOAMva RT if you want to read our newest publication “World wide characteristics, management and Outcomes of short peripheral intravenous catheters” in @JHospMedicine HT @AVATAR_grp
Latest VascLab paper with @pcarriv and @AVATAR_grp. Using computer modelling to help understand why SO many peripheral IV catheters fail! @PerkinsComms@uwanews@UWAEMS https://t.co/fXZAizMHZD